Evidence map›Paper›PMID 39758597›Full record

ArticleJTO clinical and research reports2025

Brief Report: Precision Language and Deletion of the "S" Word.

Ciara Lockstadt, Mary M Pasquinelli, Jill Feldman, Jamie L Studts, Jamie S Ostroff, Li Liu, Ella A Kazerooni, Robert A Smith, Lisa Carter-Bawa, Lawrence E Feldman

Abstract read
In one paragraph

Article in JTO clinical and research reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Reducing Stigma in Lung Cancer Screening: Co-Design of a Targeted Resource for Health Professionals in Australia.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ciara LockstadtDepartment of Internal Medicine, College of Medicine, University of Kentucky, Lexington, Kentucky.
Mary M PasquinelliDivision of Pulmonary, Critical Care, Sleep and Allergy, College of Medicine, University of Illinois Chicago, Chicago, Illinois.
Jill FeldmanEGFR Resisters, Deerfield, Illinois.
Jamie L StudtsDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
Jamie S OstroffDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Hospital of New York, New York, New York.
Li LiuSchool of Public Health, University of Illinois Chicago, Chicago, Illinois.
Ella A KazerooniDepartments of Radiology & Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Robert A SmithDivision of Early Cancer Detection Science, American Cancer Society, Atlanta, Georgia.
Lisa Carter-BawaCancer Prevention Precision Control Institute, Center for Discovery & Innovation at Hackensack Meridian Health, Nutley, New Jersey.
Lawrence E FeldmanDivision of Hematology and Oncology, College of Medicine, University of Illinois Chicago, Chicago, Illinois.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Introduction: In 2021, the International Association for the Study of Lung Cancer (IASLC) published the IASLC Language Guide as guidance on preferred language and phrasing in oral and written communications, including presentations at conferences. This study analyzed presentations from the 2022 IASLC World Conference on Lung Cancer (WCLC) one year after implementation of the Language Guide to identify adoption rates of non-stigmatizing language and to determine correlations with presenter characteristics. Methods: We downloaded 522 slide presentations from the IASLC WCLC 2022 conference attendee portal. We searched each presentation, including images, for discussion of tobacco use and the use of the term "smoker," which is an indicator of stigmatizing language. We conducted internet searches to gather presenters' stated home continent, sex, specialty, and professional degree. Results: Of 177 presentations that discussed smoking status, 77 presenters used non-stigmatizing language, whereas 100 presenters used the stigmatizing term "smoker." Male MDs and female PhDs and non-medicine subspecialties and advocates were more likely to use non-stigmatizing language. Conclusions: Encouragingly, only after one year post-release of the Language Guide, more than one-third of the presenters at the WCLC used non-stigmatizing language. This finding represents a step toward improving respectful and inclusive language surrounding smoking within the thoracic oncology community.

Identifiers

PMID39758597
PMCPMC11699356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.